Biologicals in psoriasis
JPAD-Journal of Pakistan Association of Dermatologists. 2008; 18 (2): 100-109
en Inglés
| IMEMR
| ID: emr-88421
ABSTRACT
During the recent years, a new class of therapeutic agents has been introduced for the treatment of psoriasis and psoriatic arthritis. These agents target different inflammatory mediators involved in the pathogenesis of disease. The focus of this article is on the mechanism of action, side effect profile and dosing of the agents currently in use today for the treatment of psoriasis
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Terapia Biológica
/
Proteínas Recombinantes de Fusión
/
Factor de Necrosis Tumoral alfa
/
Receptores del Factor de Necrosis Tumoral
/
Anticuerpos Monoclonales
Idioma:
Inglés
Revista:
J. Pak. Assoc. Dermatol.
Año:
2008
Similares
MEDLINE
...
LILACS
LIS